Section Arrow
Quote
ALKS.NASDAQ
- Alkermes plc
Quotes are at least 15-min delayed:2025/11/07 13:27 EST
Regular Hours
Last
 32.1
+0.42 (+1.33%)
Day High 
32.215 
Prev. Close
31.68 
1-M High
36.3164 
Volume 
518.68K 
Bid
32.08
Ask
32.12
Day Low
31.41 
Open
31.89 
1-M Low
28.41 
Market Cap 
5.23B 
Currency USD 
P/E 15.76 
%Yield -- 
10-SMA 30.68 
20-SMA 30.95 
50-SMA 29.72 
52-W High 36.45 
52-W Low 25.165 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.01/1.66
Enterprise Value
5.30B
Balance Sheet
Book Value Per Share
10.50
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
1.56B
Operating Revenue Per Share
9.63
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ORGOOrganogenesis Holdings5.6+1.71+43.96%60.5PE
TLRYTilray Brands1.22+0.01+0.83%-- 
CGCCanopy Growth Corp1.1699+0.0799+7.33%-- 
HIMSHims & Hers Health40.305-1.215-2.93%77.62PE
IXHLIncannex Healthcare0.3437-0.0204-5.60%-- 
Quotes are at least 15-min delayed：2025/11/07 13:27 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.